GB933108A - Improvements in or relating to pharmaceutical iron preparations - Google Patents
Improvements in or relating to pharmaceutical iron preparationsInfo
- Publication number
- GB933108A GB933108A GB2470/61A GB247061A GB933108A GB 933108 A GB933108 A GB 933108A GB 2470/61 A GB2470/61 A GB 2470/61A GB 247061 A GB247061 A GB 247061A GB 933108 A GB933108 A GB 933108A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ferrous
- succinate
- preparations
- iron
- aneurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical iron preparations for oral administration comprise a mixture of a ferrous compound and, as a promoter of iron absorption, a succinate in an amount more than equivalent to the ferrous compound, both said ferrous compound and said succinate being physiologically innocuous and readily soluble in gastric or intestinal fluids or both. The succinate is succinic acid, succinic anhydride or a salt of succinic acid, e.g. the sodium, ammonium or magnesium salt. Specified iron salts are ferrous sulphate, ferrous chloride, ferrous gluconate and ferrous sulphate-glycine complex. Optional ingredients are: (a) stabilizing agents, e.g. sorbitol and ascorbic acid, (b) surface-active agents, (c) pH regulators, (d) vitamins, and (e) flavour essences and sugar. The preparations may be put up in the form of solutions, syrups, capsules and tablets. Specified vitamins are riboflavin, sodium riboflavin-5-phosphate, aneurine hydrochloride, aneurine mononitrate, nicotinamide, pantothenic acid, pyridoxine hydrochloride and Vitamin B12.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE101260 | 1960-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB933108A true GB933108A (en) | 1963-08-08 |
Family
ID=20257439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2470/61A Expired GB933108A (en) | 1960-02-03 | 1961-01-20 | Improvements in or relating to pharmaceutical iron preparations |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE599466A (en) |
ES (1) | ES264510A1 (en) |
FR (1) | FR904M (en) |
GB (1) | GB933108A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1827419A2 (en) * | 2004-12-22 | 2007-09-05 | Drugtech Corporation | Methods and compositions for enhancing iron absorption |
WO2008005217A2 (en) * | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Iron(ii)-containing treatments for hyperphosphatemia |
JP2014051535A (en) * | 2013-12-19 | 2014-03-20 | Fujifilm Corp | Method of promoting absorption of iron, calcium, and magnesium |
US8986669B2 (en) | 2005-09-02 | 2015-03-24 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
CN113559118A (en) * | 2021-08-04 | 2021-10-29 | 中国科学院水生生物研究所 | Application of ferrous ions in preventing and treating carp herpesvirus II (CyHV2) infection |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2642420B1 (en) * | 1989-01-27 | 1991-09-06 | Valpan Sa Labo Pharma | NEW FORMAL RELEASE GALENIC FORM CONTAINING A COMBINATION OF FERROUS SALTS, SUCCINIC ACID AND ASCORBIC ACID |
-
1961
- 1961-01-20 GB GB2470/61A patent/GB933108A/en not_active Expired
- 1961-01-25 BE BE599466A patent/BE599466A/en unknown
- 1961-01-31 ES ES0264510A patent/ES264510A1/en not_active Expired
- 1961-02-03 FR FR851607A patent/FR904M/fr active Active
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1827419A2 (en) * | 2004-12-22 | 2007-09-05 | Drugtech Corporation | Methods and compositions for enhancing iron absorption |
EP1827418A2 (en) * | 2004-12-22 | 2007-09-05 | Drugtech Corporation | Compositions including iron |
JP2008525442A (en) * | 2004-12-22 | 2008-07-17 | ドラッグテック コーポレイション | Composition containing iron |
JP2008525445A (en) * | 2004-12-22 | 2008-07-17 | ドラッグテック コーポレイション | Methods and compositions for enhancing iron absorption |
EP1827419A4 (en) * | 2004-12-22 | 2011-08-17 | Drugtech Corp | Methods and compositions for enhancing iron absorption |
EP1827418A4 (en) * | 2004-12-22 | 2011-08-24 | Drugtech Corp | Compositions including iron |
US8986669B2 (en) | 2005-09-02 | 2015-03-24 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
WO2008005217A2 (en) * | 2006-07-05 | 2008-01-10 | Genzyme Corporation | Iron(ii)-containing treatments for hyperphosphatemia |
WO2008005217A3 (en) * | 2006-07-05 | 2008-02-21 | Genzyme Corp | Iron(ii)-containing treatments for hyperphosphatemia |
US20130243720A1 (en) * | 2006-07-05 | 2013-09-19 | Chad Huval | Iron(II)-Containing A Treatments for Hyperphosphatemia |
JP2014051535A (en) * | 2013-12-19 | 2014-03-20 | Fujifilm Corp | Method of promoting absorption of iron, calcium, and magnesium |
CN113559118A (en) * | 2021-08-04 | 2021-10-29 | 中国科学院水生生物研究所 | Application of ferrous ions in preventing and treating carp herpesvirus II (CyHV2) infection |
Also Published As
Publication number | Publication date |
---|---|
ES264510A1 (en) | 1961-10-01 |
BE599466A (en) | 1961-05-16 |
FR904M (en) | 1961-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1078874A (en) | Therapeutic compositions | |
GB933108A (en) | Improvements in or relating to pharmaceutical iron preparations | |
GB975387A (en) | Multivitamin compositions | |
US3829561A (en) | Iron preparation and process for its manufacture | |
GB1210968A (en) | Improvements in or relating to the treatment of gastric ailments | |
US2519487A (en) | Multivitamin preparation | |
GB1294299A (en) | Isoniazid derivative | |
Brise | Effect of surface-active agents on iron absorption | |
IL41347A (en) | Mineral salt preparation | |
US3655882A (en) | Stable dietary supplement for new born pigs | |
GB972672A (en) | Pharmaceutical preparations containing compounds of the androstane series | |
GB911482A (en) | Pharmaceutical tablets comprising a synergistic combination including salts of ª--phenoxyethyl penicillin | |
IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
JPS646214A (en) | Remedy for ulcerative colonopathy | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
McLean et al. | STUDIES ON HEPATIC NECROSIS INDUCED BY DIETARY MEANS: V. THE INFLUENCE OF THYROID ACTIVITY ON THE PRODUCTION OF HEPATIC NECROSIS BY DIETARY MEANS | |
GB908634A (en) | Pharmaceutical compositions containing pararosaniline or derivatives thereof | |
ES377523A1 (en) | Compound of germanic acid and cysteine | |
IE38235B1 (en) | Preparations for combatting swine dysentery | |
GB653026A (en) | Vitamin preparations | |
GB890638A (en) | Compositions for combating retinitis pigmentosa | |
GB967133A (en) | Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives | |
JPS54132221A (en) | Water-based medicine for vaginal administration | |
GB1422745A (en) | Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same | |
GB1490247A (en) | Process for preparing mono-and di-esters of 2,5-dihydroxybenzene sulphonic acid |